128 related articles for article (PubMed ID: 34118837)
1. Early response to neoadjuvant chemotherapy helps decrease recurrence rate of cervical cancer: a systematic review and meta-analysis.
Hou Q; Shen J; Zhou S; Wei J; Wu M; Chen Q; Yan W; Zhang P; Yue Q; Wang S; Huang K
Ann Palliat Med; 2021 Jun; 10(6):6092-6103. PubMed ID: 34118837
[TBL] [Abstract][Full Text] [Related]
2. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
3. The association between short-term response and long-term survival for cervical cancer patients undergoing neoadjuvant chemotherapy: a system review and meta-analysis.
Kong SY; Huang K; Zeng C; Ma X; Wang S
Sci Rep; 2018 Jan; 8(1):1545. PubMed ID: 29367687
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer.
He L; Wu L; Su G; Wei W; Liang L; Han L; Kebria M; Liu P; Chen C; Yu Y; Zhong M; Wang W
Gynecol Oncol; 2014 Aug; 134(2):419-25. PubMed ID: 24918866
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis showing that early response to neoadjuvant chemotherapy predicts better survival among cervical cancer patients.
Chen Z; Shi Y; Wang S; Lu Q
Oncotarget; 2017 Aug; 8(35):59609-59617. PubMed ID: 28938664
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer.
Rydzewska L; Tierney J; Vale CL; Symonds PR
Cochrane Database Syst Rev; 2010 Jan; (1):CD007406. PubMed ID: 20091632
[TBL] [Abstract][Full Text] [Related]
7. Establishing the prognostic value of platelet-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis.
Yang L; Chen H
Int J Gynecol Cancer; 2019 May; 29(4):683-690. PubMed ID: 30739081
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis.
Xu Y; Zhang M; Zhang J; Ng DM; Chen X; Si Y; Shi Y; Li X; Mao D; Yang L
Taiwan J Obstet Gynecol; 2021 May; 60(3):433-441. PubMed ID: 33966724
[TBL] [Abstract][Full Text] [Related]
9. Responsiveness of neoadjuvant chemotherapy before surgery predicts favorable prognosis for cervical cancer patients: a meta-analysis.
Ye Q; Yuan HX; Chen HL
J Cancer Res Clin Oncol; 2013 Nov; 139(11):1887-98. PubMed ID: 24022086
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
11. Early response to neoadjuvant chemotherapy can help predict long-term survival in patients with cervical cancer.
Li X; Huang K; Zhang Q; Shen J; Zhou H; Yang R; Wang L; Liu J; Zhang J; Sun H; Jia Y; Du X; Wang H; Deng S; Ding T; Jiang J; Lu Y; Li S; Wang S; Ma D
Oncotarget; 2016 Dec; 7(52):87485-87495. PubMed ID: 27557523
[TBL] [Abstract][Full Text] [Related]
12. The role of neoadjuvant chemotherapy for resectable colorectal liver metastases: a systematic review and meta-analysis.
Liu W; Zhou JG; Sun Y; Zhang L; Xing BC
Oncotarget; 2016 Jun; 7(24):37277-37287. PubMed ID: 27074564
[TBL] [Abstract][Full Text] [Related]
13. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria.
Hu T; Li S; Chen Y; Shen J; Li X; Huang K; Yang R; Wu L; Chen Z; Jia Y; Wang S; Cheng X; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Xu H; Xu J; Zhang Q; Xi L; Deng D; Wang H; Wang S; Lv W; Wang C; Xie X; Ma D
Eur J Cancer; 2012 Oct; 48(15):2353-60. PubMed ID: 22503395
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 cases.
Xia LY; Hu QL; Zhang J; Xu WY; Li XS
World J Surg Oncol; 2020 Jun; 18(1):129. PubMed ID: 32539858
[TBL] [Abstract][Full Text] [Related]
15. Skeletal Muscle Change During Neoadjuvant Therapy and Its Impact on Prognosis in Patients With Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.
Xu XY; Jiang XM; Xu Q; Xu H; Luo JH; Yao C; Ding LY; Zhu SQ
Front Oncol; 2022; 12():892935. PubMed ID: 35692760
[TBL] [Abstract][Full Text] [Related]
16. Acquired treatment response from neoadjuvant chemotherapy predicts a favorable prognosis for local advanced cervical cancer: A meta-analysis.
Zhu Y; Yang J; Zhang X; Chen D; Zhang S
Medicine (Baltimore); 2018 Apr; 97(17):e0530. PubMed ID: 29703026
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis.
Wang Q; Feng X; Liu X; Zhu S
Front Oncol; 2022; 12():868061. PubMed ID: 35463345
[TBL] [Abstract][Full Text] [Related]
18. The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
Mao Y; Qu Q; Zhang Y; Liu J; Chen X; Shen K
PLoS One; 2014; 9(12):e115103. PubMed ID: 25501357
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Chemotherapy Followed by Chemoradiation in Cervical Carcinoma: A Review.
de Azevedo CR; Thuler LC; de Mello MJ; Ferreira CG
Int J Gynecol Cancer; 2016 May; 26(4):729-36. PubMed ID: 26905327
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis.
Liu J; Li Y; Zhang W; Yang C; Yang C; Chen L; Ding M; Zhang L; Liu X; Cui G; Liu Y
Front Surg; 2022; 9():971030. PubMed ID: 36386510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
